{
    "clinical_study": {
        "@rank": "112698", 
        "arm_group": [
            {
                "arm_group_label": "Standard", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Conservative", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Investigators hypothesized that goal-directed fluid therapy using stroke volume variation\n      will improve postoperative recovery in patients undergoing free flap reconstruction after\n      head and neck cancer resection. Investigators will compare the effect of goal-directed fluid\n      therapy using stroke volume variation on recovery in patients undergoing free flap\n      reconstruction after head and neck cancer resection."
        }, 
        "brief_title": "Effect of Goal-directed Fluid Therapy Using Stroke Volume Variation in Patients Undergoing Free Flap Reconstruction After Head and Neck Cancer Resection", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "General Anesthesia", 
        "condition_browse": {
            "mesh_term": "Head and Neck Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult patients of age over 20 years scheduled for free flap reconstruction after head\n             and neck cancer resection\n\n        Exclusion Criteria:\n\n          -  valvular heart disease\n\n          -  congestive heart failure\n\n          -  liver failure\n\n          -  renal failure\n\n          -  pregnant woman\n\n          -  allergy to hydroxyethyl starch solutions\n\n          -  coagulation abnormalities"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003066", 
            "org_study_id": "4-2013-0638"
        }, 
        "intervention": [
            {
                "arm_group_label": "Standard", 
                "description": "In Standard fluid therapy group, the administration of fluid will be guided to maintain mean blood pressure more than 65 mmHg, urine output more than 0.5 ml/kg/hr, and central venous pressure less than 14 mmHg.", 
                "intervention_name": "Standard fluid therapy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Conservative", 
                "description": "In Goal directed fluid therapy group, the administration of fluid will be guided by stroke volume variation. The anesthesiologist will infuse volulyte (Fresenius Kabi, Bad Homburg, Germany) 200 ml if stroke volume variation is over 12%. If cardiac index is below 2.5 l/min/m2 and stroke volume variation is below 12%, start dobutamine.", 
                "intervention_name": "Conservative fluid therapy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fluid Therapy", 
            "Head and Neck Neoplasms", 
            "Surgical Flaps"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "contact": {
                "email": "koobn@yuhs.ac", 
                "last_name": "Bon-Nyeo Koo, MD", 
                "phone": "82-2-2228-2420"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine, Yonsei University Health System"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "koobn@yuhs.ac", 
            "last_name": "Bon-Nyeo Koo, MD", 
            "phone": "82-2-2228-2420"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Length of hospital stay", 
            "safety_issue": "Yes", 
            "time_frame": "1 month after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003066"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}